140 related articles for article (PubMed ID: 15905598)
1. Proton pump inhibitors for acid suppression in the intensive care unit: formulary considerations.
Devlin JW
Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S24-30. PubMed ID: 15905598
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor formulary considerations in the acutely ill. Part 1: Pharmacology, pharmacodynamics, and available formulations.
Devlin JW; Welage LS; Olsen KM
Ann Pharmacother; 2005 Oct; 39(10):1667-77. PubMed ID: 16118266
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.
Devlin JW; Welage LS; Olsen KM
Ann Pharmacother; 2005 Nov; 39(11):1844-51. PubMed ID: 16204393
[TBL] [Abstract][Full Text] [Related]
4. Formulary management of proton pump inhibitors.
Byrne MF; Murray FE
Pharmacoeconomics; 1999 Sep; 16(3):225-46. PubMed ID: 10558037
[TBL] [Abstract][Full Text] [Related]
5. Overview of pharmacologic agents for acid suppression in critically ill patients.
Welage LS
Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S4-S10. PubMed ID: 15905600
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding.
Erstad BL
Crit Care Med; 2004 Jun; 32(6):1277-83. PubMed ID: 15187506
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
9. Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding.
Olsen KM
Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S18-23. PubMed ID: 15905596
[TBL] [Abstract][Full Text] [Related]
10. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
Laine L; Shah A; Bemanian S
Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor treatment for acute peptic ulcer bleeding.
Leontiadis GI; McIntyre L; Sharma VK; Howden CW
Cochrane Database Syst Rev; 2004; (3):CD002094. PubMed ID: 15266462
[TBL] [Abstract][Full Text] [Related]
12. Gastric acid inhibition in the treatment of peptic ulcer hemorrhage.
Ghassemi KA; Kovacs TO; Jensen DM
Curr Gastroenterol Rep; 2009 Dec; 11(6):462-9. PubMed ID: 19903422
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach?
Peterson K; Bjorkman DJ
Am J Gastroenterol; 2016 Oct; 111(10):1399-1401. PubMed ID: 27694876
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of intravenous proton pump inhibitors in high-risk bleeders.
van Zanten SV
Can J Gastroenterol; 2004 Dec; 18(12):749-50. PubMed ID: 15605141
[No Abstract] [Full Text] [Related]
16. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
[TBL] [Abstract][Full Text] [Related]
17. Formulary Substitution of Proton Pump Inhibitors Based on Acquisition Price: Changes in Usage and Costs of Acid-Suppressant Therapies.
MacLaren R; Kiser TH; Jung R; Fish DN
P T; 2006 Dec; 31(12):716-734. PubMed ID: 34522075
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis: comparison of oral vs. intravenous proton pump inhibitors in patients with peptic ulcer bleeding.
Tsoi KK; Hirai HW; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):721-8. PubMed ID: 23915096
[TBL] [Abstract][Full Text] [Related]
19. Optimizing proton pump inhibitor therapy for treatment of nonvariceal upper gastrointestinal bleeding.
Worden JC; Hanna KS
Am J Health Syst Pharm; 2017 Feb; 74(3):109-116. PubMed ID: 28122752
[TBL] [Abstract][Full Text] [Related]
20. Intravenous proton pump inhibitor therapy: a rationale for use.
Armstrong D
Rev Gastroenterol Disord; 2005; 5 Suppl 2():S18-30. PubMed ID: 16369224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
